SEC Filing Details

Breadcrumb

Investors // Sec filings Sec filing 3 3 //

SEC Filing Details

Document Details

Form
Filing Date
Jan 15, 2020
Document Date
Jan 9, 2020
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Novelion Therapeutics
Issuer
NOVELION THERAPEUTICS INC.
Filer
Broadfin Capital, LLC